 |
|
|
|
|
Publications
2. Viel JF, Arveux P, Baverel J, Cahn JY. Soft-tissue sarcoma and non-Hodgkin's lymphoma clusters around a municipal solid waste incinerator with high dioxin emission levels. Am J Epidemiol 2000;152(1):13-9.
3. Trétarre B, Guizard A, Fontaine D, FRANCIM R, CépiDC-Inserm. Cancer du sein chez la femme: incidence et mortalité, France 2000. BEH 2004;44.
4. Schraub S, Mercier M, Arveux P. [Quality of life measure in cancerology]. Presse Med 2000;29(6):310-8.
5. Sant M, Allemani C, Berrino F, Coleman MP, Aareleid T, Chaplain G, Coebergh JW, Colonna M, Crosignani P, Danzon A, Federico M, Gafa L, Grosclaude P, Hedelin G, Mace-Lesech J, Garcia CM, Moller H, Paci E, Raverdy N, Tretarre B, Williams EM. Breast carcinoma survival in Europe and the United States. Cancer 2004;100(4):715-22.
6. Salame N, Viel JF, Arveux P, Delbosc B. Cancer transmission through corneal transplantation. Cornea 2001;20(7):680-2.
7. Salame N, Pitard A, Queguiner F, Boissier F, Delbosc B. [Quality of life after corneal transplantation: a retrospective study]. J Fr Ophtalmol 2003;26(10):1016-22.
8. Rolland P, Arveux P, Brochard P, Galateau F, Pairon JC, Astoul P, Elia S, Frenay C, Imbernon E, M G. Programme National de Surveillance du Mésothéliome. Archives des Maladies Professionnelles 2001;62:132-34.
9. Remontet L, Esteve J, Bouvier AM, Grosclaude P, Launoy G, Menegoz F, Exbrayat C, Tretare B, Carli PM, Guizard AV, Troussard X, Bercelli P, Colonna M, Halna JM, Hedelin G, Mace-Lesec'h J, Peng J, Buemi A, Velten M, Jougla E, Arveux P, Le Bodic L, Michel E, Sauvage M, Schvartz C, Faivre J. Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Sante Publique 2003;51(1 Pt 1):3-30.
10. Remontet L, EstèveJ, Bouvier AM, Grosclaude P, Launoy G, Menegoz F, Exbrayat C, Tretarre B, Carli PM, Guizard AV, Troussard X, Bercelli P, Colonna M, Halna JM, Hedelin G, Macé-Lesech J, Peng J, Buémi A, Velten M, Jougla E, Arveux P, Le Bodic L, Michel E, Sauvage M, Schvartz C, J F. Estimations nationales: tendances de l'incidence et de la mortalité par cancer en France entre 1978 et 2000. BEH 2003;41-42.
11. Queneau PE, Pitard A, Labourey JM, Koch S, Sauve G, Carayon P. [Trends for the management of pancreatic adenocarcinoma in a hospitalized-based population (1980-1994)]. Gastroenterol Clin Biol 2000;24(5):501-5.
12. Pitard A, Colonna M, Villet H. [Estimation of cancer incidence in departments without cancer registries]. Bull Cancer 2001;88(10):1036-8.
13. Phelip JM, Milan C, Herbert C, Grosclaude P, Arveux P, Raverdy N, Daures JP, Faivre J. Evaluation of the management of rectal cancers before and after the consensus conference in France. Eur J Gastroenterol Hepatol 2004;16(10):1003-9.
14. Phelip JM, Launoy G, Colonna M, Grosclaude P, Velten M, Danzon A, Raverdy N, Tretarre B, Bouvier AM, Faivre J. Regional variations in management of rectal cancer in France. Gastroenterol Clin Biol 2004;28(4):378-83.
15. Phelip JM, Grosclaude P, Launoy G, Colonna M, Danzon A, Velten M, Tretarre B, Bouvier AM, Faivre J. Are there regional differences in the management of colon cancer in France? Eur J Cancer Prev 2005;14(1):31-7.
16. Peng J, Menegoz F, Lesec'h JM, Remontet L, Grosclaude P, Buemi A, Guizard AV, Tretarre B, Danzon A, Velten M, Maarouf N, Jougla E, Launoy G, Dubreuil A. [Larynx cancer in France: descriptive epidemiology and incidence estimation]. Bull Cancer 2004;91(4):363-8.
17. Morales-Suarez-Varela MM, Olsen J, Johansen P, Kaerlev L, Guenel P, Arveux P, Wingren G, Hardell L, Ahrens W, Stang A, Llopis A, Merletti F, Aurrekoetxea JJ, Masala G. Occupational risk factors for mycosis fungoides: a European multicenter case-control study. J Occup Environ Med 2004;46(3):205-11.
18. Morales Suarez-Varela MM, Olsen J, Kaerlev L, Guenel P, Arveux P, Wingren G, Hardell L, Ahrens W, Stang A, Llopis-Gonzalez A, Merletti F, Guillen-Grima F, Johansen P. Are alcohol intake and smoking associated with mycosis fungoides? A European multicentre case-control study. Eur J Cancer 2001;37(3):392-7.
19. Morales MM, Olsen J, Johansen P, Kaerlev L, Guenel P, Arveux P, Wingren G, Hardell L, Ahrens W, Stang A, Llopis A, Merletti F, Villanueva MA. Viral infection, atopy and mycosis fungoides: a European multicentre case-control study. Eur J Cancer 2003;39(4):511-6.
20. Montanaro F, Bray F, Gennaro V, Merler E, Tyczynski JE, Parkin DM, Strnad M, Jechov'a M, Storm HH, Aareleid T, Hakulinen T, Velten M, Lef'evre H, Danzon A, Buemi A, Daur'es JP, Menegoz F, Raverdy N, Sauvage M, Ziegler H, Comber H, Paci E, Vercelli M, De Lisi V, Tumino R, Zanetti R, Berrino F, Stanta G, Langmark F, Rachtan J, Mezyk R, Blaszczyk J, Ivan P, Primic-Zakelj M, Martinez AC, Izarzugaza I, Borras J, Garcia CM, Garau I, Sanchez NC, Aicua A, Barlow L, Torhorst J, Bouchardy C, Levi F, Fisch T, Probst N, Visser O, Quinn M, Gavin A, Brewster D, Mikov M. Pleural mesothelioma incidence in Europe: evidence of some deceleration in the increasing trends. Cancer Causes Control 2003;14(8):791-803.
21. Menegoz F, Lesec HJ, Rame JP, Reyt E, Bauvin E, Arveux P, Buemi A, Raverdy N, Schaffer P. [Lip, oral cavity and pharynx cancers in France: incidence, mortality and trends (period 1975-1995)]. Bull Cancer 2002;89(4):419-29.
22. Limat S, Woronoff-Lemsi MC, Milpied N, Chartrin I, Ifrah N, Deconinck E, Gressin R, Colombat P, Cahn JY, Arveux P. Effect of cell determinant (CD)34+ cell dose on the cost and consequences of peripheral blood stem cell transplantation for non-Hodgkin's lymphoma patients in front-line therapy. Eur J Cancer 2000;36(18):2360-7.
23. Hedelin G, Remontet L., Reseau FRANCIM. Evolution du cancer du testicule en France. Andrologie 2002;12:269-73.
24. Grosclaude P, Colonna M, Hedelin G, Tretarre B, Arveux P, Lesec'h JM, Raverdy N, Sauvage-Machelard M. Survival of women with breast cancer in france: variation with age, stage and treatment. Breast Cancer Res Treat 2001;70(2):137-43.
25. Floret N, Mauny F, Challier B, Arveux P, Cahn JY, Viel JF. Dioxin emissions from a solid waste incinerator and risk of non-Hodgkin lymphoma. Epidemiology 2003;14(4):392-8.
26. Desandes E, Lacour B, Sommelet D, Buemi A, Danzon A, Delafosse P, Grosclaude P, Mace-Lesech J, Raverdy-Bourdon N, Tretarre B, Velten M, Brugieres L. Cancer incidence among adolescents in France. Pediatr Blood Cancer 2004;43(7):742-8.
27. Colonna M, Hedelin G, Esteve J, Grosclaude P, Launoy G, Buemi A, Arveux P, Tretarre B, Chaplain G, Lesec'h JM, Raverdy N, Carli PM, Menegoz F, Faivre J. National cancer prevalence estimation in France. Int J Cancer 2000;87(2):301-4.
28. Colonna M, Grosclaude P, Remontet L, Schvartz C, Mace-Lesech J, Velten M, Guizard A, Tretarre B, Buemi AV, Arveux P, Esteve J. Incidence of thyroid cancer in adults recorded by French cancer registries (1978-1997). Eur J Cancer 2002;38(13):1762-8.
29. Colonna M, Grosclaude P, Remontet L, Schvartz C, Francim, CepiDC. Incidence des cancers thyroidiens chez l'adulte en France: analyse à partir des données des registres de cancer. BEH 2003;35:165-67.
30. Colonna M, Grosclaude P, Remontet L, Schvartz C, Francim, CepiDC. Incidence des cancers thyroidiens chez l'adulte en France: situation en France en 2000. Médecine Clinique endocrinologie et diabète 2003;6:40-44.
31. Colonna M, Grosclaude P, Launoy G, Tretarre B, Arveux P, Raverdy N, Benhamiche AM, Herbert C, Faivre J. Estimation of colorectal cancer prevalence in France. Eur J Cancer 2001;37(1):93-6.
32. Colonna M, Grosclaude P, Launoy G, Arveux P, Buemi A, Raverdy N, Schaffer P, Tretarre B, Exbrayat C, Faivre J. [Estimate of regional prevalence of colorectal cancer in France]. Rev Epidemiol Sante Publique 2002;50(3):243-51.
33. Chirpaz E, Colonna M, Menegoz F, Grosclaude P, Schaffer P, Arveux P, Lesec'h JM, Exbrayat C, Schaerer R. Incidence and mortality trends for prostate cancer in 5 French areas from 1982 to 1996. Int J Cancer 2002;97(3):372-6.
34. Chérié-Challine L, Halna JM, Remontet L. Situation épidémiologique du mélanome cutané et impact en terme de prévention. BEH 2004;2.
35. Brochard P, Arveux P, Galateau F, Astoul P, Pairon JC, Elia S, M G. Programme National de Surveillance du Mésothéliome. Estimation provisoire de l'incidence nationale du mésothéliome pleural à partir du Programme National de Surveillance du Mésothéliome. BEH 2002;3:11-13.
36. Bouvier AM, Remontet L, Jougla E, Launoy G, Grosclaude P, Buemi A, Tretarre B, Velten M, Dancourt V, Menegoz F, Guizard AV, Mace Lesec'h J, Peng J, Bercelli P, Arveux P, Esteve J, Faivre J. Incidence of gastrointestinal cancers in France. Gastroenterol Clin Biol 2004;28(10 Pt 1):877-81.
37. Benessahraoui M, Dalstein V, Lorchel F, Algros MP, Puzenat E, Louvat P, Hassam B, Humbert PH, Aubin F. [Merkel cell carcinoma: descriptive study of 24 cases (1993-2001)]. Rev Med Interne 2003;24(9):560-8.
38. Bauvin E, Remontet L, Grosclaude P, Francim. [Incidence and mortality of prostate cancer in France: trends between 1978 and 2000]. Prog Urol 2003;13(6):1334-9.
39. Aubin F, Puzenat E, Arveux P, Louvat P, Quencez E, Humbert P. Genital squamous cell carcinoma in men treated by photochemotherapy. A cancer registry-based study from 1978 to 1998. Br J Dermatol 2001;144(6):1204-6.
40. Allemani C, Sant M, Berrino
F, Aareleid T, Chaplain G, Coebergh JW, Colonna M, Contiero P, Danzon
A, Federico M, Gafa L, Grosclaude P, Hedelin G, Mace-Lesech J, Garcia
CM, Paci E, Raverdy N, Tretarre B, Williams EM. Prognostic
value of morphology and hormone receptor status in breast cancer - a population-based
study. Br J Cancer 2004;91(7):1263-8.
Le Registre fait parti des groupes EUROCARE, EUROPREVAL et ENCR
1. Sant M. Differences in stage and therapy for breast cancer across Europe. Int J Cancer 2001;93(6):894-901.
2. Sant M, Capocaccia R, Coleman MP, Berrino F, Gatta G, Micheli A, Verdecchia A, Faivre J, Hakulinen T, Coebergh JW, Martinez-Garcia C, Forman D, Zappone A. Cancer survival increases in Europe, but international differences remain wide. Eur J Cancer 2001;37(13):1659-67.
3. Capocaccia R, Colonna M, Corazziari I, De Angelis R, Francisci S, Micheli A, Mugno E. Measuring cancer prevalence in Europe: the EUROPREVAL project. Ann Oncol 2002;13(6):831-9.
4. Micheli A, Mugno E, Krogh V, Quinn MJ, Coleman M, Hakulinen T, Gatta G, Berrino F, Capocaccia R. Cancer prevalence in European registry areas. Ann Oncol 2002;13(6):840-65.
5. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer Incidence in Five Continents Volume VIII. Lyon: International Agency for Research on Cancer; 2002.
6. Verdecchia A, Micheli A, Colonna M, Moreno V, Izarzugaza MI, Paci E. A comparative analysis of cancer prevalence in cancer registry areas of France, Italy and Spain. Ann Oncol 2002;13(7):1128-39.
7. Botha JL, Bray F, Sankila R, Parkin DM. Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer 2003;39(12):1718-29.
8. Capocaccia R, Gatta G, Roazzi P, Carrani E, Santaquilani M, De Angelis R, Tavilla A. The EUROCARE-3 database: methodology of data collection, standardisation, quality control and statistical analysis. Ann Oncol 2003;14 Suppl 5:v14-27.
9. Coleman MP, Gatta G, Verdecchia A, Esteve J, Sant M, Storm H, Allemani C, Ciccolallo L, Santaquilani M, Berrino F. EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol 2003;14 Suppl 5:v128-49.
10. de Vries E, Bray FI, Coebergh JW, Parkin DM. Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia. Int J Cancer 2003;107(1):119-26.
11. Gatta G, Capocaccia R, De Angelis R, Stiller C, Coebergh JW. Cancer survival in European adolescents and young adults. Eur J Cancer 2003;39(18):2600-10.
12. Gatta G, Corazziari I, Magnani C, Peris-Bonet R, Roazzi P, Stiller C. Childhood cancer survival in Europe. Ann Oncol 2003;14 Suppl 5:v119-27.
13. Janssen-Heijnen ML, Coebergh JW. The changing epidemiology of lung cancer in Europe. Lung Cancer 2003;41(3):245-58.
14. Micheli A, Baili P, Quinn M, Mugno E, Capocaccia R, Grosclaude P. Life expectancy and cancer survival in the EUROCARE-3 cancer registry areas. Ann Oncol 2003;14 Suppl 5:v28-40.
15. Montanaro F, Bray F, Gennaro V, Merler E, Tyczynski JE, Parkin DM, Strnad M, Jechov'a M, Storm HH, Aareleid T, Hakulinen T, Velten M, Lef'evre H, Danzon A, Buemi A, Daur'es JP, Menegoz F, Raverdy N, Sauvage M, Ziegler H, Comber H, Paci E, Vercelli M, De Lisi V, Tumino R, Zanetti R, Berrino F, Stanta G, Langmark F, Rachtan J, Mezyk R, Blaszczyk J, Ivan P, Primic-Zakelj M, Martinez AC, Izarzugaza I, Borras J, Garcia CM, Garau I, Sanchez NC, Aicua A, Barlow L, Torhorst J, Bouchardy C, Levi F, Fisch T, Probst N, Visser O, Quinn M, Gavin A, Brewster D, Mikov M. Pleural mesothelioma incidence in Europe: evidence of some deceleration in the increasing trends. Cancer Causes Control 2003;14(8):791-803.
16. Roazzi P, Capocaccia R, Santaquilani M, Carrani E. Electronic availability of EUROCARE-3 data: a tool for further analysis. Ann Oncol 2003;14 Suppl 5:v150-5.
17. Sant M, Aareleid T, Berrino F, Bielska Lasota M, Carli PM, Faivre J, Grosclaude P, Hedelin G, Matsuda T, Moller H, Moller T, Verdecchia A, Capocaccia R, Gatta G, Micheli A, Santaquilani M, Roazzi P, Lisi D. EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary. Ann Oncol 2003;14 Suppl 5:v61-118.
18. Sant M, Allemani C, Capocaccia R, Hakulinen T, Aareleid T, Coebergh JW, Coleman MP, Grosclaude P, Martinez C, Bell J, Youngson J, Berrino F. Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer 2003;106(3):416-22.
19. de Vries E, Bray FI, Eggermont AM, Coebergh JW. Monitoring stage-specific trends in melanoma incidence across Europe reveals the need for more complete information on diagnostic characteristics. Eur J Cancer Prev 2004;13(5):387-95.
20. Steliarova-Foucher E, Stiller
C, Kaatsch P, Berrino F, Coebergh JW, Lacour B, Parkin M. Geographical
patterns and time trends of cancer incidence and survival among children
and adolescents in Europe since the 1970s (the ACCISproject): an epidemiological
study. Lancet 2004;364(9451):2097-105.
Etude sur les cancers rares (INSERM) :
1. Guenel
P, Cyr D, Sabroe S, Lynge E, Merletti F, Ahrens W, Baumgardt-Elms C, Menegoz
F, Olsson H, Paulsen S, Simonato L, Wingren G Alcohol
drinking may increase risk of breast cancer in men: a European population-based
case-control study. Cancer Causes Control - Aug 2004 (Vol. 15,
Issue 6, Pages 571-80)
2. Guenel, P., L. Laforest, D. Cyr, J. Fevotte, S. Sabroe, C. Dufour, J. M. Lutz and E. Lynge (2001). "Occupational risk factors, ultraviolet radiation, and ocular melanoma: a case-control study in France." Cancer Causes Control 12(5): 451-9.
3. Kaerlev L, Teglbjaerg PS, Sabroe S, Kolstad HA, Ahrens W, Eriksson M, Guenel P, Hardell L, Launoy G, Merler E, Merletti F, Stang A Medical risk factors for small-bowel adenocarcinoma with focus on Crohn disease: a European population-based case-control study. Scand J Gastroenterol - Jun 2001 (Vol. 36, Issue 6, Pages 641-6)
4. Kaerlev L, Teglbjaerg PS, Sabroe S, Kolstad HA, Ahrens W, Eriksson M, Guenel P, Hardell L, Launoy G, Merler E, Merletti F, Stang A, Olsen J Is there an association between alcohol intake or smoking and small bowel adenocarcinoma? Results from a European multi-center case-control study.Cancer Causes Control - Oct 2000 (Vol. 11, Issue 9, Pages 791-7)
5. Kaerlev, L., . Teglbjaerg, S. Sabroe, H. A. Kolstad, W. Ahrens, M. Eriksson, A. L. Gonzalez, P. Guenel, L. Hardell, G. Launoy, E. Merler, F. Merletti, M. M. Suarez-Varela and A. Stang "Occupation and small bowel adenocarcinoma: a European case-control study." Occup Environ Med (2000).57(11): 760-6.
6. Kaerlev, L., . Teglbjaerg, S. Sabroe, H. A. Kolstad, W. Ahrens, M. Eriksson, P. Guenel, G. Gorini, L. Hardell, D. Cyr, P. Zambon, A. Stang and J. Olsen (2002). "The importance of smoking and medical history for development of small bowel carcinoid tumor: a European population-based case-control study." Cancer Causes Control 13(1): 27-34.
7. Kaerlev, L., . Teglbjaerg, S. Sabroe, H. A. Kolstad, W. Ahrens, M. Eriksson, P. Guenel, L. Hardell, D. Cyr, T. Ballard, P. Zambon, M. M. Morales Suarez-Varela, A. Stang and J. Olsen. "Occupational risk factors for small bowel carcinoid tumor: a European population-based case-control study." J Occup Environ Med (2002) 44 (6): 516-22.
8. Kaerlev, L., P. S. Teglbjaerg, S. Sabroe, H. A. Kolstad, W. Ahrens, M. Eriksson, P. Guenel, L. Hardell, G. Launoy, E. Merler, F. Merletti and A. Stang (2001). "Medical risk factors for small-bowel adenocarcinoma with focus on Crohn disease: a European population-based case-control study." Scand J Gastroenterol 36(6): 641-6.
9. Lynge, E., N. Afonso, L. Kaerlev,
J. Olsen, S. Sabroe, W. Ahrens, M. Eriksson, P. Guenel, F. Merletti, A.
Stengrevics, M. Suarez-Varela, A. Costa-Pererra and M. Vyberg (2005). "European
multi-centre case-control study on risk factors for rare cancers of unknown
aetiology." Eur J Cancer 41(4): 601-12.
Autres études :
1. Floret
N, Mauny F, Challier B, Cahn JY, Tourneux F, Viel JF. [Dioxin emissions
and soft-tissue sarcoma: results of a population-based case-control study].
Rev Epidemiol Sante Publique 2004;52(3):213-20.
2. Matsuda T, Remontet L, Grosclaude
P. [Incidence of bladder cancer in France: trends from 1980 to 2000]. Prog
Urol 2003;13(4):602-7.
Contribution du Registre à la production
de DEA, de thèses et de mémoires - 2000-2004
Les thèses d’université :
Stagiaires :